Compliance Certificate under Reg. 74(5) of SEBI (DP) Regulations 2018 is enclosed
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Godavari Drugs has submitted a routine compliance certificate to BSE under SEBI's Regulation 74(5) for the quarter ended 31 March 2025. The certificate was issued by CIL Securities Limited, the company's Registrar and Share Transfer Agent. It confirms that share dematerialisation requests received from Depository Participants during the quarter were properly processed, verified, and reflected in the company's Register of Members. The filing is a standard regulatory formality and not related to any business or operational event.
No material impact on shareholders or the stock price. This is a routine procedural filing required by SEBI to ensure smooth processing of share dematerialisation, indicating normal compliance housekeeping.